Status: Recruiting
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).
Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Well Cell GlobalUpdated: Oct 20, 2025Locations: 1
Eligibility criteria
Is age 18 or older (male or female) [+9]
Has in the past two (2) years received treatment for a malignancy. [+15]